Drug
Insulin Glargine Recombinant
Insulin Glargine Recombinant: highest development phase Approved, developed by Sanofi. 1 trial record tracked on RxWires.
- Highest phase
- Approved
- Developer
- Sanofi
Trials
| Drug | Phase | Indication |
|---|---|---|
| TOUJEO | Approved |
Latest
Follow Insulin Glargine Recombinant on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.